Tempest Therapeutics announces up to $7.5 million private placement
Valid market news retained in the public archive without immediate LiveCast distribution.
Story updates
12:01:20 PM UTC
SquawkNews
$2.5 million upfront with up to approximately $5 million of potential aggregate gross proceeds upon the exercise in full of warrantsBRISBANE, Calif., Sept. 11, 2026 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. NASDAQ:TPST (the “Company”), a clinical-stage biotechnology company pioneering the dev…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.